19018-Lung Cancer-NA-1519

Lung Cancer

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy and Checkpoint Inhibitor Therapy (SAPPHIRE)

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Address

1105 Central Expressway, Suite 320
Allen, TX 75013
P: (469) 467-4392

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.